USA Financial Formulas’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2
Closed -$366 398
2023
Q3
$366 Hold
2
﹤0.01% 474
2023
Q2
$471 Hold
2
﹤0.01% 435
2023
Q1
$406 Buy
+2
New +$416 ﹤0.01% 382
2022
Q3
$0 Hold
2
﹤0.01% 333
2022
Q2
$0 Hold
2
﹤0.01% 364
2022
Q1
$0 Sell
2
-4,767
-100% -$1.12M ﹤0.01% 388
2021
Q4
$1.4M Buy
+4,769
New +$1.33M 1.2% 45
2020
Q3
Sell
-11,499
Closed -$1.98M 336
2020
Q2
$1.98M Buy
+11,499
New +$1.7M 1.47% 25
2019
Q4
Sell
-18,738
Closed -$2.64M 251
2019
Q3
$2.64M Buy
+18,738
New +$2.64M 1.02% 54
2016
Q4
Sell
-21,521
Closed -$2.9M 279
2016
Q3
$2.9M Buy
+21,521
New +$2.85M 0.74% 45
2015
Q3
Sell
-23,184
Closed -$2.25M 123
2015
Q2
$2.25M Buy
+23,184
New +$2.26M 0.69% 38

Other funds holding EFX

USA Financial Formulas's EFX Position: Q4 2023 in Review

USA Financial Formulas sold out of Equifax (EFX) in Q4 2023, closing a stake of 2 shares — an estimated $366 sold.

USA Financial Formulas first reported a position in EFX in Q2 2015 and held it in 11 quarters. The position peaked at $2.9M in Q3 2016. 728 funds tracked by Wall St. Rank hold EFX as of Q4 2023.

  • USA Financial Formulas reported no remaining Equifax position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 2 Equifax shares in Q4 2023, an estimated $366.
  • USA Financial Formulas first reported a position in Equifax in Q2 2015 and held it in 11 quarters.
  • USA Financial Formulas's Equifax position peaked at $2.9M in Q3 2016.
  • 728 funds tracked by Wall St. Rank held Equifax as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.